Exosomes are extracellular signalosomes that facilitate eukaryotic intercellular communication under a wide range of normal physiological contexts. In malignancies, this regulatory circuit is co-opted to promote cancer cell survival and outgrowth. Tumour-derived exosomes (TDEs) carry a pro-EMT (epithelial–mesenchymal transition) programme including transforming growth factor beta (TGFβ), caveolin-1, hypoxia-inducible factor 1 alpha (HIF1α), and β-catenin that enhances the invasive and migratory capabilities of recipient cells, and contributes to stromal remodelling and premetastatic niche formation. The integrin expression patterns on TDEs appear to dictate their preferential uptake by organ-specific cells, implying a crucial role of this pathway in organotropic metastasis. Through the expression of immunomodulatory molecules such as CD39 and CD73, TDEs modify the immune contexture of the tumour microenvironment, which could have implications for immunotherapy. Hence, targeting TDE dysregulation pathways, such as the heparanase/syndecan-1 axis, could represent novel therapeutic strategies in the quest to conquer cancer.
How exosomes mediate cancer metastasis
Key Points:
- Tumour-derived exosomes (TDEs) contain prodigious amounts of epithelial–mesenchymal transition (EMT) inducers, and transduce EMT characteristics in recipient epithelial cells.
- Exosomes are being implicated in the aetiology of organotropic metastasis owing to their target-homing ability and capacity to form a premetastatic niche at specific organ sites.
- Exosomes may be hijacked by tumour viruses and may confer oncogenic potential or induce malignant transformation in recipient cells.
- TDEs have potent immunomodulatory effects that likely foster tumour escape from immunosurveillance.
- Pharmacological agents that directly or indirectly modulate tumour exosome biogenesis, secretion, and function have also shown promising antimetastatic activity.
Article: Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance
Source: Trends in Pharmacological Sciences | Cell Press
Link: http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(16)30017-7
Edited
Latest News
A signaling molecule that potently stimulates hair growth
New pathway for accumulation of age-promoting 'zombie cells'
Protecting the brain from dementia-inducing abnormal protein aggregates
Why many cancer cells need to import fat
Role of nonsense-mediated mRNA decay (NMD) in fragile X-syndrome
Other Top Stories
Untangling the proteins that trigger some cancerous tumors
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
An omega-3 fatty acid kills tumor by ferroptosis
Extracellular mRNA transported to the nucleus prevents cancer metastasis
Cancer immunotherapy may self-limit its efficacy
Protocols
Light and electron microscopic imaging of synaptic vesicle endocytosis at mouse hippocampal cultures
FLAMBE: A kinetic fluorescence polarization assay to study activation of monomeric BAX
Single-cell mass spectrometry
A behavioral paradigm for measuring perceptual distances in mice
Rapid detection of an Ebola biomarker with optical microring resonators
Publications
Cough hypersensitivity and chronic cough
Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening
The why and how of adaptive immune responses in ischemic cardiovascular disease
Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's d…
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER